We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$180B
AUM Growth
+$20.4B
Cap. Flow
+$6.1B
Cap. Flow %
3.39%
Top 10 Hldgs %
26.13%
Holding
7,254
New
260
Increased
3,541
Reduced
2,314
Closed
700

Sector Composition

Rank Sector Weight
1 Technology 8.85%
2 Healthcare 5.77%
3 Financials 5.26%
4 Consumer Discretionary 4.71%
5 Communication Services 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLM icon
5601
CALL
SLM Corp
SLM
$4.89B
$57K ﹤0.01%
6,400
-2,800
-30% -$24.3K
LGF.B
5602
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$57K ﹤0.01%
5,747
-211,106
-97% -$1.82M
WIRE
5603
PUT
DELISTED
Encore Wire Corp
WIRE
$57K ﹤0.01%
1,000
-600
-38% -$34.4K
RVLP
5604
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$57K ﹤0.01%
8,226
+4,174
+103% +$22.3K
KLDO
5605
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$57K ﹤0.01%
11,363
+8,876
+357% +$56.4K
AXAS
5606
DELISTED
Abraxas Petroleum Corp
AXAS
$57K ﹤0.01%
8,163
+4,101
+101% +$26.4K
TD icon
5607
PUT
Toronto Dominion Bank
TD
$198B
$56K ﹤0.01%
+1,000
New +$56.7K
TITN icon
5608
CALL
Titan Machinery
TITN
$396M
$56K ﹤0.01%
3,800
-3,900
-51% -$60.8K
TZOO icon
5609
Travelzoo
TZOO
$74.3M
$56K ﹤0.01%
5,257
+2,632
+100% +$27.3K
VHI icon
5610
Valhi
VHI
$380M
$56K ﹤0.01%
2,481
+1,264
+104% +$29K
ZSL icon
5611
CALL
ProShares UltraShort Silver
ZSL
$65.4M
$56K ﹤0.01%
13
EVLO
5612
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$56K ﹤0.01%
693
+352
+103% +$39.4K
TEUM
5613
DELISTED
Pareteum Corporation
TEUM
$56K ﹤0.01%
128,735
+74,295
+136% +$42.9K
HIG icon
5614
PUT
Hartford Financial Services
HIG
$38.9B
$55K ﹤0.01%
900
-4,600
-84% -$276K
SND icon
5615
Smart Sand
SND
$185M
$55K ﹤0.01%
22,060
-19,507
-47% -$48.2K
VHC icon
5616
CALL
VirnetX Holding Corp
VHC
$54.4M
$55K ﹤0.01%
725
+260
+56% +$26.1K
VNCE icon
5617
Vince Holding Corp
VNCE
$81.3M
$55K ﹤0.01%
3,204
+1,633
+104% +$34.2K
KB icon
5618
KB Financial Group
KB
$41.4B
$54K ﹤0.01%
1,311
TS icon
5619
CALL
Tenaris
TS
$28.9B
$54K ﹤0.01%
2,400
-2,100
-47% -$45.1K
UGL icon
5620
PUT
ProShares Ultra Gold
UGL
$650M
$54K ﹤0.01%
4,400
-400
-8% -$4.72K
EWGS
5621
DELISTED
iShares MSCI Germany Small-Cap ETF
EWGS
$54K ﹤0.01%
900
HEDJ icon
5622
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.83B
$53K ﹤0.01%
1,502
-152,794
-99% -$5.27M
WBS icon
5623
PUT
Webster Financial
WBS
$12.5B
$53K ﹤0.01%
+1,000
New +$48.1K
ASND icon
5624
Ascendis Pharma A/S
ASND
$16B
$52K ﹤0.01%
378
-8,233
-96% -$915K
CXT icon
5625
PUT
Crane NXT
CXT
$2.99B
$52K ﹤0.01%
1,727
+863
+100% +$24.6K

Similar funds

Barclays's Q4 2019 Portfolio in Review

As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.

  • Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
  • Barclays added most to Apple in Q4 2019, an estimated $572M increase.
  • Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
  • Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
  • Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
  • Barclays opened 260 new positions and closed 700 in Q4 2019.
  • Barclays's portfolio value rose 13% quarter-over-quarter to $180B.

Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.